BackJiangsu Hengrui Medicine , Ltd. Overview

Jiangsu Hengrui Medicine , Ltd. Profit Margin

Jiangsu Hengrui Medicine , Ltd. (600276.SS) has a profit margin of 27.06%, above the sector sector average of 13.4%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

27.45%
↑ 56.71% YoY

As of Sep 2026

Annual Profit Margin (TTM)

27.06%
↑ 12.26% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Jiangsu Hengrui Medicine , Ltd. (600276.SS) FAQ

Jiangsu Hengrui Medicine , Ltd. posts a profit margin of 27.06% as of September 2026. That compares with 24.1% in the prior-year period — up 12.3% year over year. That is above the sector sector average of 13.4%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Jiangsu Hengrui Medicine , Ltd.'s profit margin was 24.1%. The latest reading is 27.06% — a 12.3% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.4% is typical. Jiangsu Hengrui Medicine , Ltd.'s 27.06% is higher that level. That is roughly 101.9% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Jiangsu Hengrui Medicine , Ltd.'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 27.06% as of September 2026; use YoY and peer views to separate noise from signal.

Context for 600276.SS's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.4%), and (3) consistency with growth and profitability. This page covers the first two; Jiangsu Hengrui Medicine , Ltd.'s other metric pages and overview cover the third.